Concepedia

Author

Yuta Takagaki

Kanazawa Medical UniversityORCID

Also Known As

Takagaki Y, Takagaki, Yuta, YUTA TAKAGAKI, Yuta Takagaki

31

Publications

919

Citations

10

H-Index

22

Concepts

All Affiliations

Kanazawa Medical UniversityShimane University
YT

About

Yuta Takagaki is an author at Kanazawa Medical University specializing in metabolic syndrome, chronic kidney disease, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

309

2

Cell Biology

2

2

309

3

Diabetes

2

2

309

4

Nephrology

2

2

309

5

Health Sciences

1

1

78

Yuta Takagaki

×

10

Publications

886

Citations

10

H-Index

YearCitations

Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules

Jinpeng Li, Haijie Liu, Susumu Takagi,

JCI Insight

2020

231

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial–Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis

Fan Yang, Yuta Takagaki, Yasuo Yoshitomi,

Cancer Research

2018

133

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet

Susumu Takagi, Jinpeng Li, Yuta Takagaki,

Journal of Diabetes Investigation

2018

122

Endothelial autophagy deficiency induces IL6 - dependent endothelial mesenchymal transition and organ fibrosis

Yuta Takagaki, Seon Myeong Lee, Zha Dongqing,

Autophagy

2020

114

The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation

Haijie Liu, Yuta Takagaki, Asako Kumagai,

Journal of Diabetes Investigation

2020

100

Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys

Swayam Prakash Srivastava, Jinpeng Li, Yuta Takagaki,

iScience

2021

78

Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling

Emi Kawakita, Fan Yang, Asako Kumagai,

Molecular Cancer Research

2020

58

Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice

Yuta Takagaki, Sen Shi, Makoto Katoh,

Scientific Reports

2019

28

CD‐1<i><sup>db/db</sup></i> mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis

Yuiko Mizunuma, Keizo Kanasaki, Kyoko Nitta,

Journal of Diabetes Investigation

2020

12

Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice

Taro Hirai, Munehiro Kitada, Itaru Monno,

Journal of Diabetes Investigation

2021

10

Page 1